Metrohm AG of Herisau, Switzerland, has acquired B&W Tek’s Spectroscopy Solution Business, B&W Tek LLC, and several overseas subsidiaries.
Metrohm AG of Herisau, Switzerland, has acquired B&W Tek’s Spectroscopy Solution Business, B&W Tek LLC, and several overseas subsidiaries. B&W Tek is located in Newark, Delaware.
CEO and President of Metrohm AG Christoph Fässler said in a statement “We are pleased to strengthen our product portfolio in spectroscopy by the acquisition of B&W Tek’s R&D, production, and sales organizations.”
Jack Zhou, who is the CEO of B&W Tek LLC, said that he and his company are excited to see the accelerated growth potential and how it will further a focus on customer-centric solutions and innovations. “The addition of complementary products and technologies by B&W Tek, together with Metrohm’s expertise in products and commercialization as well as market presence will allow us to serve a much larger global customer base,” he said.
Although the details about the acquisition are confidential, B&W Tek will continue to operate under its own brand with its own service and sales organization for now. Following a transition period, the gradual integration of B&W Tek into the Metrohm organization will take place.
An Interview with AES Mid-Career Award Recipient Jason Dwyer
July 25th 2024Jason Dwyer of the University of Rhode Island has been named the recipient of the American Electrophoresis Society’s Mid-Career Award, which honors exceptional contributions to the field of electrophoresis, microfluidics, and related areas by an individual who is currently in the middle of their career.
Glucose's Impact on Brain Cancer Cells Unveiled Through Raman Imaging
July 25th 2024Researchers have used Raman spectroscopy and chemometric methods to reveal how glucose affects normal and cancerous brain cell metabolism. Their findings highlight specific biomarkers that can distinguish metabolic changes, potentially aiding in cancer research and treatment.